JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.14% |
| 2 | Technology | 13.12% |
| 3 | Financials | 12.1% |
| 4 | Healthcare | 9.54% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
iShares S&P 500 Value ETF
IVE
$49.2B
| $905M | 0.17% |
6,956,597
-7,206
| -0.1% | -$897K |
2013 Q2
26 quarters
|
|
127
Vanguard Dividend Appreciation ETF
VIG
$111B
| $899M | 0.17% |
7,211,031
+3,048,757
| +73% | +$369M |
2013 Q2
26 quarters
|
|
128
iShares S&P 500 Growth ETF
IVW
$79.7B
| $899M | 0.17% |
18,567,112
-97,064
| -0.5% | -$4.5M |
2013 Q2
26 quarters
|
|
129
Nike
NKE
$51.9B
| $877M | 0.16% |
8,654,627
+602,089
| +7% | +$56.8M |
2013 Q2
26 quarters
|
|
130
Amphenol
APH
$213B
| $865M | 0.16% |
63,939,384
-378,472
| -0.6% | -$4.83M |
2013 Q2
26 quarters
|
|
131
Edison International
EIX
$21B
| $861M | 0.16% |
11,415,261
-5,529,854
| -33% | -$391M |
2013 Q2
26 quarters
|
|
132
Lowe's Companies
LOW
$104B
| $857M | 0.16% |
7,158,350
+321,999
| +5% | +$36.8M |
2013 Q2
26 quarters
|
|
133
NXP Semiconductors
NXPI
$57.4B
| $848M | 0.16% |
6,665,150
-169,982
| -2% | -$19.7M |
2013 Q3
25 quarters
|
|
134
Royal Caribbean
RCL
$75.1B
| $847M | 0.16% |
6,344,265
-1,618,001
| -20% | -$189M |
2013 Q2
26 quarters
|
|
135
ServiceNow
NOW
$146B
| $844M | 0.16% |
14,947,325
-6,321,320
| -30% | -$333M |
2013 Q2
26 quarters
|
|
136
iShares Russell Mid-Cap ETF
IWR
$56.5B
| $843M | 0.16% |
14,145,275
+497,687
| +4% | +$28.6M |
2013 Q2
26 quarters
|
|
137
Illinois Tool Works
ITW
$75B
| $842M | 0.16% |
4,689,045
-665,180
| -12% | -$113M |
2013 Q2
26 quarters
|
|
138
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.21B
| $840M | 0.16% |
9,468,415
+5,171,822
| +120% | +$462M |
2018 Q2
6 quarters
|
|
139
Qualcomm
QCOM
$185B
| $832M | 0.16% |
9,428,630
+434,218
| +5% | +$36.3M |
2013 Q2
26 quarters
|
|
140
iShares MSCI India ETF
INDA
$5.72B
| $829M | 0.15% |
23,571,752
+4,439,687
| +23% | +$152M |
2014 Q4
20 quarters
|
|
141
Entergy
ETR
$49B
| $824M | 0.15% |
13,755,682
+9,406,572
| +216% | +$554M |
2013 Q2
26 quarters
|
|
142
CALL
iShares Morningstar Value ETF
ILCV
$1.34B
| $819M | 0.15% |
18,800,000
+15,487,400
| +468% | +$880M |
2016 Q4
12 quarters
|
|
143
American Express
AXP
$207B
| $813M | 0.15% |
6,534,368
+603,593
| +10% | +$72.1M |
2013 Q2
26 quarters
|
|
144
iShares TIPS Bond ETF
TIP
$14.2B
| $813M | 0.15% |
6,970,893
-2,254,823
| -24% | -$262M |
2013 Q2
26 quarters
|
|
145
MetLife
MET
$62.2B
| $807M | 0.15% |
15,842,595
+921,123
| +6% | +$44.5M |
2013 Q2
26 quarters
|
|
146
Equinix
EQIX
$101B
| $803M | 0.15% |
1,375,850
-91,391
| -6% | -$51.4M |
2014 Q3
21 quarters
|
|
147
Amgen
AMGN
$222B
| $800M | 0.15% |
3,319,937
+2,054,336
| +162% | +$453M |
2013 Q2
26 quarters
|
|
148
KeyCorp
KEY
$21.3B
| $790M | 0.15% |
39,050,846
-8,381,060
| -18% | -$158M |
2013 Q2
26 quarters
|
|
149
DexCom
DXCM
$31.7B
| $789M | 0.15% |
14,421,976
-3,532
| -0% | -$168K |
2015 Q3
17 quarters
|
|
150
Trane Technologies
TT
$106B
| $777M | 0.14% |
5,845,578
+893,318
| +18% | +$113M |
2013 Q2
26 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.